The Hepatitis C Viral Combo Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect the presence of Hepatitis C virus (HCV) in an individual's blood. This test is crucial for identifying both acute and chronic infections of HCV, a blood-borne virus that can cause liver disease, including cirrhosis and liver cancer. The combo test typically includes screening for HCV antibodies (anti-HCV) to determine past or present infection, as well as a nucleic acid test (NAT) for HCV RNA, which confirms active infection. Priced at 1920 AED, this test is a vital resource for early detection, enabling timely treatment and management of the condition, thereby reducing the risk of severe liver damage and associated health complications. DNA Labs UAE provides this test with a commitment to accuracy, confidentiality, and comprehensive support for those being tested.
The "Immunosuppressant Drug Profile 1 Test" is a specialized diagnostic examination offered at DNA Labs UAE, designed to monitor and measure the levels of certain immunosuppressive drugs in the bloodstream. This test is particularly crucial for patients who have undergone organ transplants or those being treated for autoimmune diseases, as it helps in ensuring that the dosage of immunosuppressant medication is optimal. By maintaining the right balance, the test aids in preventing organ rejection while minimizing the risk of drug toxicity.
The cost of the test is 1920 AED, reflecting the intricate nature of the analysis and the sophisticated technology utilized to achieve accurate results. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures reliability and precision, providing essential information for the effective management of immunosuppressive therapy. This test is a key component in the personalized treatment plans for patients requiring immunosuppression, enabling healthcare providers to make informed decisions regarding dosage adjustments and overall treatment strategies.
The "Immunosuppressant Drug Profile 4 Test" is a specialized medical examination offered by DNA Labs UAE, designed to measure the levels of certain immunosuppressant drugs in the bloodstream. This test is particularly crucial for individuals who have undergone organ transplantation or those being treated for autoimmune diseases, as it helps in ensuring that the dosage of immunosuppressant medications is optimal. By monitoring the concentration of these drugs, healthcare providers can adjust dosages to prevent organ rejection while minimizing the risk of drug toxicity.
The test covers a specific panel of immunosuppressant drugs, although the exact drugs included in "Profile 4" are not specified here. These drugs typically include agents like cyclosporine, tacrolimus, sirolimus, and mycophenolate mofetil, among others, which are commonly used to suppress the immune system in various clinical scenarios.
Administered at DNA Labs UAE, a facility known for its state-of-the-art diagnostic services, the test ensures accuracy and reliability in results. The cost of the "Immunosuppressant Drug Profile 4 Test" is set at 1920 AED. Given the critical nature of immunosuppressant therapy in transplant and autoimmune disease management, this test plays a vital role in patient care, ensuring that therapeutic levels are maintained for efficacy while reducing the risk of adverse effects.
The "Vibrio Cholerae Multiplex Detection and Differentiation of O1, Non-O1, O139, and Ctx Gene RNA Detection Qualitative Test" is a sophisticated diagnostic assay conducted at DNA Labs UAE, aimed at identifying and distinguishing between various strains of the Vibrio cholerae bacteria, which is responsible for causing cholera, a potentially life-threatening gastroenteric infection. This comprehensive test is capable of detecting the presence of the O1 and O139 serogroups, which are commonly associated with epidemic and pandemic outbreaks, as well as Non-O1 strains that are often linked to sporadic cases of cholera. Additionally, it includes the detection of the cholera toxin (Ctx) gene, a critical virulence factor in the pathology of the disease.
The test employs advanced molecular techniques to qualitatively assess the RNA of the Vibrio cholerae bacteria, ensuring high specificity and sensitivity in identifying the pathogen and its relevant strains. This is particularly important for public health surveillance, outbreak management, and guiding appropriate treatment strategies.
The cost of the test is set at 1900 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed. Conducted at DNA Labs UAE, a facility known for its state-of-the-art diagnostic capabilities and stringent quality standards, this test represents a critical tool in the fight against cholera, aiding in the rapid and accurate diagnosis of this disease.
The FISH - CLL Panel Test, offered by DNA Labs UAE, is a specialized diagnostic tool designed to detect chromosomal abnormalities in patients with Chronic Lymphocytic Leukemia (CLL). This test utilizes Fluorescence In Situ Hybridization (FISH) technology to identify specific genetic markers associated with CLL, providing valuable information that can influence treatment decisions and prognostic assessments. Priced at 1900 AED, the FISH - CLL Panel Test is a critical resource for clinicians in the management and understanding of CLL, offering insights into the genetic landscape of the disease that traditional diagnostic methods may not reveal.
The FISH (Fluorescence In Situ Hybridization) - EGFR Gene Amplification Test is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to detect amplifications of the EGFR gene within a patient's DNA. EGFR, or Epidermal Growth Factor Receptor, plays a crucial role in cell growth and division. Its amplification can be indicative of various types of cancers, including lung, breast, and colorectal cancers, making this test a vital tool in the diagnosis and management of these conditions.
The test employs fluorescent probes to bind to specific DNA sequences related to the EGFR gene. By applying these probes to cells or tissue samples, the test can highlight the presence of EGFR gene amplifications through fluorescence microscopy. This method allows for a highly sensitive and specific analysis of the genetic material, providing clinicians with critical information that can guide treatment decisions, particularly in selecting targeted therapies for cancer patients.
At DNA Labs UAE, the FISH - EGFR Gene Amplification Test is offered at a cost of 2010 AED. The price reflects the technical sophistication and the detailed, personalized insights the test provides into a patient's genetic profile. With its state-of-the-art facilities and expert staff, DNA Labs UAE ensures accurate, reliable results for this essential diagnostic test, supporting effective, personalized treatment plans for patients facing EGFR-related conditions.
The "FISH - Synovial Sarcoma SS18 SYT 18q11.2 Gene Rearrangement Test" is a diagnostic tool used to identify the specific genetic alteration associated with synovial sarcoma, a type of cancer that usually occurs near the joints of the arm, neck, or leg. This test employs Fluorescence In Situ Hybridization (FISH) technology to detect the rearrangement of the SS18 (formerly known as SYT) gene located on chromosome 18 at position q11.2. This gene rearrangement is a hallmark of synovial sarcoma and is critical for accurate diagnosis and treatment planning.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test is priced at 2010 AED. The lab utilizes advanced molecular techniques to provide precise results, which are crucial for determining the appropriate therapeutic approach and assessing prognosis. By identifying the presence of the SS18 SYT gene rearrangement, healthcare providers can confirm a diagnosis of synovial sarcoma, enabling targeted treatment strategies and potentially improving patient outcomes.
The Hepatitis C Monitoring Panel Test is a comprehensive diagnostic tool used to assess and monitor the progression or treatment response of Hepatitis C virus (HCV) infection. This panel typically includes a series of blood tests that measure the viral load (quantity of the virus in the blood), check for the presence of antibodies against the HCV, and sometimes assess the virus's genotype, which can influence treatment decisions. Additionally, liver function tests are often part of the panel to evaluate the impact of the virus on liver health.
At DNA Labs UAE, the cost for the Hepatitis C Monitoring Panel Test is set at 2010 AED. DNA Labs UAE is known for its state-of-the-art facilities and highly qualified staff, ensuring accurate and reliable test results. This test is crucial for individuals diagnosed with or suspected of having Hepatitis C, as it guides healthcare providers in making informed decisions regarding the best course of treatment and monitoring the effectiveness of therapy over time.
The "Interleukin-6 (IL-6) SARS-CoV-2 Basic Panel Test" is a specialized diagnostic assay offered by DNA Labs UAE, designed to measure the levels of Interleukin-6 (IL-6) in the blood. IL-6 is a cytokine that plays a critical role in the body's immune response to infections, including the novel coronavirus (SARS-CoV-2), which is responsible for the COVID-19 pandemic. Elevated levels of IL-6 are indicative of an inflammatory response, which can be particularly relevant in the context of severe COVID-19 cases where a cytokine storm may occur, leading to significant tissue damage and complications.
This test is crucial for clinicians to assess the severity of the infection and to make informed decisions regarding the management and treatment strategies for patients with COVID-19. It provides valuable insights into the patient's immune response and helps in identifying individuals at risk of developing severe complications, thereby facilitating timely and appropriate medical interventions.
The test is conducted at DNA Labs UAE, a reputable facility known for its state-of-the-art technology and adherence to international standards in medical diagnostics. The cost of the test is 2010 AED, reflecting the comprehensive analysis and accuracy it offers in aiding the diagnosis and management of COVID-19 patients by evaluating their immunological status through IL-6 levels.
The Thioridazine Test is a specialized diagnostic procedure aimed at measuring the levels of Thioridazine, an antipsychotic medication, in a patient's blood. This test is particularly crucial for individuals undergoing treatment with Thioridazine, as it helps in ensuring the drug is within the therapeutic range, optimizing treatment efficacy while minimizing potential side effects. Given the precise nature of this test, it is conducted in sophisticated laboratory settings such as DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the Thioridazine Test at DNA Labs UAE is set at 2010 AED, reflecting the comprehensive approach and accuracy of the test in monitoring the drug's concentration. This test is essential for healthcare providers to make informed decisions regarding dosage adjustments and to monitor the patient's response to treatment, ensuring a personalized and effective therapeutic strategy.
